Publications by authors named "Francesca Di Modugno"

Claim this Profile
E
Enhancing PDAC therapy: Decitabine-olaparib synergy targets KRAS-dependent tumors.
Giorgia Anastasio, Michela Felaco, Alessia Lamolinara, Francesco Del Pizzo, Elisa Cacciagrano, Francesca Di Modugno

iScience· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer.
Francesca Di Modugno, Anna Di Carlo, Sheila Spada, Belinda Palermo, Lorenzo D'Ambrosio

EBioMedicine· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcription factors in fibroblast plasticity and CAF heterogeneity.
Roberta Melchionna, Paola Trono, Anna Di Carlo, Francesca Di Modugno, Paola Nisticò

J Exp Clin Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin.
Vittorio Castaldo, Michele Minopoli, Francesca Di Modugno, Andrea Sacconi, Domenico Liguoro

J Exp Clin Cancer Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC.
Paola Trono, Annalisa Tocci, Belinda Palermo, Anna Di Carlo, Lorenzo D'Ambrosio, Francesca Di Modugno

J Immunother Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy.
Silvia Baldari, Francesca Di Modugno, Paola Nisticò, Gabriele Toietta

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology.
Sheila Spada, Annalisa Tocci, Francesca Di Modugno, Paola Nisticò

J Exp Clin Cancer Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation.
Roberta Melchionna, Sheila Spada, Francesca Di Modugno, Daniel D'Andrea, Anna Di Carlo

EMBO Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D models in the new era of immune oncology: focus on T cells, CAF and ECM.
Francesca Di Modugno, Cristina Colosi, Paola Trono, Giuseppe Antonacci, Giancarlo Ruocco

J Exp Clin Cancer Res· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis.
Francesca Di Modugno, Sheila Spada, Belinda Palermo, Paolo Visca, Pierluigi Iapicca

Oncogene· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.
Francesca Di Modugno, Valentina Caprara, Lidia Chellini, Piera Tocci, Francesca Spadaro

Proc Natl Acad Sci U S A· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting.
Antonella Sistigu, Francesca Di Modugno, Gwenola Manic, Paola Nisticò

Cytokine Growth Factor Rev· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis.
Moitza Principe, Simone Borgoni, Mariafrancesca Cascione, Michelle Samuel Chattaragada, Sammy Ferri-Borgogno, Francesca Di Modugno

J Hematol Oncol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome.
Roberta Melchionna, Pierluigi Iapicca, Francesca Di Modugno, Paola Trono, Isabella Sperduti

Oncoimmunology· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
hMENA(11a), a hMENA isoform sending survival signals.
Paola Trono, Francesca Di Modugno, Paola Nisticò

Mol Cell Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β1 and β4 integrins: from breast development to clinical practice.
Paola Nisticò, Francesca Di Modugno, Sheila Spada, Mina J Bissell

Breast Cancer Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.
Emilio Bria, Francesca Di Modugno, Isabella Sperduti, Pierluigi Iapicca, Paolo Visca

Oncotarget· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors.
Francesca Di Modugno, Pierluigi Iapicca, Aaron Boudreau, Marcella Mottolese, Irene Terrenato

Proc Natl Acad Sci U S A· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and genetic bases of pancreatic cancer.
Vanja Vaccaro, Alain Gelibter, Emilio Bria, Pierluigi Iapicca, Paola Cappello, Francesca Di Modugno

Curr Drug Targets· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cooperation between hMena overexpression and HER2 signalling in breast cancer.
Francesca Di Modugno, Marcella Mottolese, Lucia DeMonte, Paola Trono, Michele Balsamo

PLoS One· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo.
Sumanta Goswami, Ulrike Philippar, Daqian Sun, Antonia Patsialou, Jacob Avraham, Francesca Di Modugno

Clin Exp Metastasis· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Mena+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lines.
Maria S Pino, Michele Balsamo, Francesca Di Modugno, Marcella Mottolese, Massimo Alessio

Clin Cancer Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines.
Francesca Di Modugno, Lucia DeMonte, Michele Balsamo, Giovanna Bronzi, Maria Rita Nicotra

Cancer Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors.
Francesca Di Modugno, Marcella Mottolese, Anna Di Benedetto, Andrea Conidi, Flavia Novelli

Clin Cancer Res· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response.
Francesca Di Modugno, Giovanna Bronzi, Matthew J Scanlan, Duilia Del Bello, Simona Cascioli

Int J Cancer· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis